(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -44.77%759.88M | -11.62%787.19M | -24.08%653.33M | -24.08%653.33M | -18.86%694.61M | 56.78%1.38B | -1.47%890.69M | -7.31%860.52M | -7.31%860.52M | 6.21%856.03M |
-Cash and cash equivalents | -44.77%759.88M | -11.62%787.19M | -24.08%653.33M | -24.08%653.33M | -18.86%694.61M | 56.78%1.38B | -1.47%890.69M | -7.31%860.52M | -7.31%860.52M | 6.21%856.03M |
-Accounts receivable | 19.01%1.65B | 23.00%1.59B | 15.75%1.34B | 15.75%1.34B | 13.30%1.48B | 23.04%1.39B | 30.28%1.3B | 33.31%1.16B | 33.31%1.16B | 35.21%1.31B |
Total current assets | 5.21%4.76B | 17.99%4.66B | 8.22%4B | 8.22%4B | 7.05%4B | 31.18%4.52B | 22.66%3.95B | 23.84%3.69B | 23.84%3.69B | 30.74%3.74B |
Non current assets | ||||||||||
-Accumulated depreciation | ---- | ---- | -16.36%-3.27B | -16.36%-3.27B | ---- | ---- | ---- | -11.67%-2.81B | -11.67%-2.81B | ---- |
Investment properties | ---- | ---- | --8.23M | --8.23M | ---- | ---- | ---- | ---- | ---- | ---- |
-Long term equity investment | 34.52%2.47B | 86.42%2.49B | 35.12%1.73B | 35.12%1.73B | 198.44%1.67B | 229.30%1.84B | 135.32%1.34B | 66.34%1.28B | 66.34%1.28B | -28.25%558.91M |
-Including:Available-for-sale securities | ---- | ---- | --8.23M | --8.23M | ---- | ---- | ---- | ---- | ---- | ---- |
-Including:Held to maturity investments | -88.69%4.11M | -10.57%20.62M | 132.84%32.97M | 132.84%32.97M | -59.05%19.32M | 175.68%36.32M | 15.14%23.06M | 55.62%14.16M | 55.62%14.16M | 213.47%47.19M |
Financial assets | -99.70%18K | -8.58%2.91M | 127.41%5.11M | 127.41%5.11M | 36.11%1.86M | 209.19%5.96M | -36.21%3.18M | 117.94%2.25M | 117.94%2.25M | 62.09%1.37M |
Non current note receivables | 24.83%181.43M | 12.08%178.15M | 1.60%172.83M | 1.60%172.83M | 22.24%184.4M | 4.96%145.35M | 20.97%158.95M | 29.93%170.12M | 29.93%170.12M | 29.01%150.85M |
-Goodwill | 29.31%2.37B | 28.48%2.38B | 6.59%1.99B | 6.59%1.99B | 8.85%1.96B | 1.56%1.83B | 13.94%1.85B | 11.94%1.87B | 11.94%1.87B | 6.87%1.8B |
Regulatory assets | 18.42%1.74B | 20.80%1.66B | 11.64%1.41B | 11.64%1.41B | 14.70%1.56B | 23.86%1.47B | 29.13%1.37B | 34.60%1.26B | 34.60%1.26B | 33.38%1.36B |
Non current deferred assets | -49.07%25.46M | -31.82%33.04M | -17.82%39.14M | -17.82%39.14M | -32.09%33.85M | 1.72%50M | -74.32%48.46M | -74.42%47.63M | -74.42%47.63M | -74.66%49.85M |
Total assets | -17.04%47.51M | -30.30%38.53M | -45.94%41.48M | -45.94%41.48M | 80.50%43.38M | 132.76%57.27M | 69.78%55.28M | 230.92%76.73M | 230.92%76.73M | 93.89%24.03M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | 310.96%119.84M | 331.58%120.26M | 51.61%40.53M | 51.61%40.53M | -95.44%34.22M | -95.56%29.16M | -87.61%27.87M | 26.97%26.73M | 26.97%26.73M | 3,411.89%749.86M |
-Current debt | 310.96%119.84M | 331.58%120.26M | 51.61%40.53M | 51.61%40.53M | -95.44%34.22M | -95.56%29.16M | -87.61%27.87M | 26.97%26.73M | 26.97%26.73M | 3,411.89%749.86M |
-accounts payable | 15.23%2.58B | 19.01%2.59B | 15.95%1.43B | 15.95%1.43B | 8.17%2.25B | 19.36%2.24B | 22.31%2.18B | 25.09%1.23B | 25.09%1.23B | 35.64%2.08B |
-Total tax payable | 31.28%2.78B | 72.78%2.82B | 24.95%2.01B | 24.95%2.01B | 139.15%1.97B | 156.92%2.12B | 92.78%1.63B | 53.68%1.61B | 53.68%1.61B | -21.68%824.51M |
Current accrued expenses | ---- | ---- | 19.56%744.53M | 19.56%744.53M | ---- | ---- | ---- | 34.83%622.74M | 34.83%622.74M | ---- |
Current provisions | 41.19%56.31M | 42.19%51.85M | 38.36%49.26M | 38.36%49.26M | 3.36%37.22M | 16.25%39.88M | 7.55%36.46M | -0.87%35.6M | -0.87%35.6M | 3.08%36.01M |
Current deferred liabilities | ---- | ---- | -0.82%156.2M | -0.82%156.2M | ---- | ---- | ---- | 0.25%157.49M | 0.25%157.49M | ---- |
Current liabilities | 18.15%2.83B | 21.12%2.81B | 16.81%2.52B | 16.81%2.52B | -18.26%2.42B | -8.61%2.39B | 11.38%2.32B | 23.57%2.16B | 23.57%2.16B | 76.51%2.96B |
Non current liabilities | ||||||||||
Non current accrued expenses | 28.40%3.87B | 32.05%3.87B | 30.95%3.64B | 30.95%3.64B | 26.19%3.37B | 16.35%3.02B | 22.36%2.93B | 15.37%2.78B | 15.37%2.78B | 9.52%2.67B |
Derivative product liabilities | 418.32%3.45M | -64.63%647K | -96.22%139K | -96.22%139K | -67.14%2.87M | -56.30%666K | 11,331.25%1.83M | 252.20%3.68M | 252.20%3.68M | 285.91%8.74M |
Long term provisions | 34.52%2.47B | 86.42%2.49B | 35.12%1.73B | 35.12%1.73B | 198.44%1.67B | 229.30%1.84B | 135.32%1.34B | 66.34%1.28B | 66.34%1.28B | -28.25%558.91M |
Total non current liabilities | 24.32%5.61B | 42.44%5.63B | 20.29%4.53B | 20.29%4.53B | 16.01%4.39B | 31.05%4.51B | 34.88%3.95B | 34.86%3.76B | 34.86%3.76B | 38.67%3.79B |
Shareholders'equity | ||||||||||
Share capital | 2.29%142.1M | 2.29%142.1M | 2.29%142.1M | 2.29%142.1M | 0.06%138.93M | -2.73%138.93M | -4.72%138.93M | -4.98%138.93M | -4.98%138.93M | -5.04%138.84M |
-common stock | 2.29%142.1M | 2.29%142.1M | 2.29%142.1M | 2.29%142.1M | 0.06%138.93M | -2.73%138.93M | -4.72%138.93M | -4.98%138.93M | -4.98%138.93M | -5.04%138.84M |
Additional paid-in capital | 7.16%35.73M | 7.35%34.95M | 8.99%34.18M | 8.99%34.18M | 9.69%34.13M | 9.88%33.34M | 10.07%32.56M | 8.82%31.36M | 8.82%31.36M | 12.46%31.11M |
Gains losses not affecting retained earnings | -30.30%55.11M | -21.05%91.53M | 126.36%99.4M | 126.36%99.4M | 158.67%49.43M | 168.37%79.06M | 271.59%115.94M | 269.77%43.91M | 269.77%43.91M | -1,619.58%-84.24M |
Other equity interest | 56.78%63.47M | 58.11%70.04M | 37.49%65.05M | 37.49%65.05M | --54.76M | 16.22%40.49M | --44.3M | 16.57%47.31M | 16.57%47.31M | ---- |
Total equity | 16.95%11.21B | 24.23%11.13B | 14.86%9.85B | 14.86%9.85B | 13.52%9.57B | 19.15%9.59B | 18.22%8.96B | 16.05%8.58B | 16.05%8.58B | 15.30%8.43B |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.